DEXCOM, INC. for DEXCOM, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 12, 2024 | $56,750 | Replaced |
| 2nd Quarter - Amendment (this page) | Sep 6, 2024 | $170,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
CGM Coverage policy Issues related to sterilization of medical devices Issues related to medical device electronic labeling H.R.3723, Medical Device Electronic Labeling Act H.R.1328, Medical Device Nonvisual Accessibility Act Issues related to artificial intelligence and other machine learning advances in healthcare Issues related to advances in diabetes technology
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY RAINES | — |
| BRUCE THOMAS TAYLOR | — |
Medicare/Medicaid MMM
CGM Coverage policies Issues related to Medicare coverage and payment for breakthrough medical devices H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY RAINES | — |
| BRUCE THOMAS TAYLOR | — |
Trade (domestic/foreign) TRD
Issues related to global supply chains
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY RAINES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.